Abstract
In phase I cancer clinical trials, the maximum tolerated dose of a new drug is often found by a dose-escalation method known as the A + B design. We have developed an interactive web application, AplusB, which computes and returns exact operating characteristics of A + B trial designs. The application has a graphical user interface (GUI), requires no programming knowledge and is free to access and use on any device that can open an internet browser. A customised report is available for download for each design that contains tabulated operating characteristics and informative plots, which can then be compared with other dose-escalation methods. We present a step-by-step guide on how to use this application and provide several illustrative examples of its capabilities.
Cite
CITATION STYLE
Wheeler, G. M., Sweeting, M. J., & Mander, A. P. (2016). AplusB: A web application for investigating A + B designs for phase I cancer clinical trials. PLoS ONE, 11(7). https://doi.org/10.1371/journal.pone.0159026
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.